Asia Pacific PoC Diagnostics Market Report

Asia Pacific PoC Diagnostics Market Analysis And Segment Forecasts To 2020

  • Published Date: Apr, 2014
  • Base Year for Estimate: 2013
  • Report ID: 978-1-68038-102-3
  • Format: Electronic (PDF)
  • Historical Data: 2011-2013
  • Number of Pages: 92

Table of Contents

Chapter 1. Executive Summary
                   1.1. Asia Pacific PoC Diagnostics - Industry Summary and Critical Success Factors (CSFs)
Chapter 2. Asia Pacific PoC Diagnostics Industry Outlook
                   2.1. Market Segmentation
                   2.2. Market Size and Growth Prospects
                   2.3. Asia Pacific PoC Diagnostics Market Dynamics
                       2.3.1. Market Driver Analysis
                       2.3.2. Impact Analysis of Market Drivers
                       2.3.3. Market Restraint Analysis
                       2.3.4. Impact Analysis of Market Restraints
                   2.4. Key Opportunities Prioritized
                   2.5. Industry Analysis - Porter's
                   2.6. Asia Pacific PoC Diagnostics - Company Market Share Analysis
                   2.7. Asia Pacific PoC Diagnostics Market PESTEL Analysis, 2012
Chapter 3. Asia Pacific PoC Diagnostics Product Outlook
                   3.1. Blood Gas/Electrolytes Market
                       3.1.1. Blood Gas/Electrolytes Market, (USD Million), 2012 - 2020
                   3.2. Infectious Disease Testing Market
                       3.2.1. Infectious Disease Testing Market, , 2012 - 2020 (USD Million)
                   3.3. Glucose Testing Market
                       3.3.1. Glucose Testing Market, , 2012 - 2020 (USD Million)
                   3.4. Cardiac Markers Market
                       3.4.1. Cardiac Markers Market, , 2012 - 2020 (USD Million)
                   3.5. Hematology Market
                       3.5.1. Hematology Market, , 2012 - 2020 (USD Million)
                   3.6. Coagulation Market
                       3.6.1. Coagulation Market, , 2012 - 2020 (USD Million)
                   3.7. Primary Care Systems (Lipid Profiling and HbA1C Tests) Market
                       3.7.1. Primary Care Systems (Lipid Profiling and HbA1C Tests) Market, 2012 - 2020 (USD Million)
                   3.8. Decentralized Clinical Chemistry Market
                       3.8.1. Decentralized Clinical Chemistry Market, , 2012 - 2020 (USD Million)
                   3.9. Urinalysis Market
                       3.9.1. Urinalysis Market, , 2012 - 2020 (USD Million)
                   3.10. Drug Abuse Testing Market
                       3.10.1. Drug Abuse Testing Market, , 2012 - 2020 (USD Million)
                   3.11. Fertility Market
                       3.11.1. Fertility Market, , 2012 - 2020 (USD Million)
                   3.12. OTC and Rapid Diagnostic Tests Market
                       3.12.1. OTC and Rapid Diagnostic Tests Market, , 2012 - 2020 (USD Million)
                   3.13. Feces Testing Market
                       3.13.1. Feces Testing Market, , 2012 - 2020 (USD Million)
Chapter 4. Asia Pacific PoC Diagnostics End-Use Outlook
                   4.1. Hospitals
                       4.1.1. PoC Diagnostics Based Hospitals Market Estimates and Forecasts, 2012 - 2020 (USD Million)
                   4.2. Laboratory
                       4.2.1. PoC Diagnostics Based Laboratory Market Estimates and Forecasts, 2012 - 2020 (USD Million)
                   4.3. Assisted Living Healthcare Facilities
                       4.3.1. Assisted Living Healthcare Facilities Market Estimates and Forecasts, 2012 - 2020 (USD Million)
                   4.4. Home Healthcare
                       4.4.1. PoC Diagnostics Based Home Healthcare Market Estimates and Forecasts, 2012 - 2020 (USD Million)
                   4.5. Clinics
                       4.5.1. PoC Diagnostics Based Clinics Market Estimates and Forecasts, 2012 - 2020 (USD Million)
                   4.6. Other Facilities
                       4.6.1. PoC Diagnostics Based Other Facilities Market Estimates and Forecasts, 2012 - 2020 (USD Million)
Chapter 5. Asia Pacific PoC Diagnostics Regional Outlook
                   5.1. India
                       5.1.1. India PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)
                       5.1.2. India PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)
                   5.2. Japan
                       5.2.1. Japan PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)
                       5.2.2. Japan PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)
                   5.3. China
                       5.3.1. China PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)
                       5.3.2. China PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)
                   5.4. Taiwan
                       5.4.1. Taiwan PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)
                       5.4.2. Taiwan PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)
                   5.5. Philippines
                       5.5.1. Philippines PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)
                       5.5.2. Philippines PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)
                   5.6. South Korea
                       5.6.1. South Korea PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)
                       5.6.2. South Korea PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)
                   5.7. Malaysia
                       5.7.1. Malaysia PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)
                       5.7.2. Malaysia PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)
                   5.8. Singapore
                       5.8.1. Singapore PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)
                       5.8.2. Singapore PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)
                   5.9. Indonesia
                       5.9.1. Indonesia PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)
                       5.9.2. Indonesia PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)
                   5.10. Australia
                       5.10.1. Australia PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)
                       5.10.2. Australia PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)
                   5.11. New Zealand
                       5.11.1. New Zealand PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)
                       5.11.2. New Zealand PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)
                   5.12. Thailand
                       5.12.1. Thailand PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)
                       5.12.2. Thailand PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)
                   5.13. Hong Kong
                       5.13.1. Hong Kong PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)
                       5.13.2. Hong Kong PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)
                   5.14. Vietnam
                       5.14.1. Vietnam PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)
                       5.14.2. Vietnam PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)
                   5.15. Pakistan
                       5.15.1. Pakistan PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)
                       5.15.2. Pakistan PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)
                   5.16. Rest of Asia Pacific
                       5.16.1. Rest of Asia Pacific PoC Diagnostics Market Estimates and Forecasts, by Products, 2012 - 2020 (USD Million)
                       5.16.2. Rest of Asia Pacific PoC Diagnostics Market Estimates and Forecasts, by End-Use, 2012 - 2020 (USD Million)
Chapter 6 Competitive Landscape
                   6.1 Roche Diagnostics
                       6.1.1 Company Overview
                       6.1.2 Financial Performance
                       6.1.3 Product Benchmarking
                       6.1.4 Strategic Initiatives
                   6.2 Abbott Laboratories
                       6.2.1 Company Overview
                       6.2.2 Financial Performance
                       6.2.3 Product Benchmarking
                       6.2.4 Strategic Initiatives
                   6.3 Alere Inc.
                       6.3.1 Company Overview
                       6.3.2 Financial Performance
                       6.3.3 Product Benchmarking
                       6.3.4 Strategic Initiatives
                   6.4 Siemens Healthcare
                       6.4.1 Company Overview
                       6.4.2 Financial Performance
                       6.4.3 Product Benchmarking
                       6.4.4 Strategic Initiatives
                   6.5 Danaher Corporation
                       6.5.1 Company Overview
                       6.5.2 Financial Performance
                       6.5.3 Product Benchmarking
                       6.5.4 Strategic Initiatives
                   6.6 BD
                       6.6.1 Company Overview
                       6.6.2 Financial Performance
                       6.6.3 Product Benchmarking
                       6.6.4 Strategic Initiatives
                   6.7 Abaxis Inc.
                       6.7.1 Company Overview
                       6.7.2 Financial Performance
                       6.7.3 Product Benchmarking
                       6.7.4 Strategic Initiatives
                   6.8 Nova Biomedical
                       6.8.1 Company Overview
                       6.8.2 Financial Performance
                       6.8.3 Product Benchmarking
                       6.8.4 Strategic Initiatives
                   6.9 Instrumentation Laboratory
                       6.9.1 Company Overview
                       6.9.2 Financial Performance
                       6.9.3 Product Benchmarking
                       6.9.4 Strategic Initiatives
                   6.10 Sysmex
                       6.10.1 Company Overview
                       6.10.2 Financial Performance
                       6.10.3 Product Benchmarking
                       6.10.4 Strategic Initiatives
                   6.11 Johnson and Johnson
                       6.11.1 Company Overview
                       6.11.2 Financial Performance
                       6.11.3 Product Benchmarking
                       6.11.4 Strategic Initiatives
                   6.12 Radiometer
                       6.12.1 Company Overview
                       6.12.2 Financial Performance
                       6.12.3 Product Benchmarking
                       6.12.4 Strategic Initiatives
                   6.13 Qiagen
                       6.13.1 Company Overview
                       6.13.2 Financial Performance
                       6.13.3 Product Benchmarking
                       6.13.4 Strategic Initiatives
                   6.14 Spectral Diagnostics
                       6.14.1 Company Overview
                       6.14.2 Financial Performance
                       6.14.3 Product Benchmarking
                       6.14.4 Strategic Initiatives
                   6.15 OraSure
                       6.15.1 Company Overview
                       6.15.2 Financial Performance
                       6.15.3 Product Benchmarking
                       6.15.4 Strategic Initiatives
                   6.16 Quidel Corporation
                       6.16.1 Company Overview
                       6.16.2 Financial Performance
                       6.16.3 Product Benchmarking
                       6.16.4 Strategic Initiatives
                   6.17 Sekisui Diagnostics
                       6.17.1 Company Overview
                       6.17.2 Financial Performance
                       6.17.3 Product Benchmarking
                       6.17.4 Strategic Initiatives
Chapter 7. Methodology and Scope
                   7.1. Research Methodology
                   7.2. Research Scope & Assumption
                   7.3. List of Data Sources


List of Tables

1. Asia Pacific PoC Diagnostics - Industry summary & Critical Success Factors (CSFs)
2. Asia Pacific PoC market revenue, 2012 - 2020 (USD million)
3. Asia Pacific PoC market revenue, by products, 2012 - 2020 (USD million)
4. Asia Pacific PoC market revenue, by end user, 2012 - 2020 (USD million)
5. Asia Pacific PoC market revenue, by country, 2012 - 2020 (USD million)
6. Asia Pacific PoC diagnostics – Key market driver analysis
7. Diabetes prevalence, top 10 countries, 2013
8. Asia Pacific PoC Diagnostics – Key market restraint analysis
9. Asia Pacific PoC glucose testing revenue, 2012 - 2020, (USD Million)
10. Asia Pacific point of care OTC and rapid diagnostic tests revenue, 2012 - 2020 (USD million)
11. Asia Pacific point of care cardiac markers revenue, 2012 - 2020 (USD million)
12. Asia Pacific point of care fertility diagnostics revenue, 2012 - 2020 (USD million)
13. Asia Pacific point of care blood gas and electrolytes diagnostics revenue, 2012 - 2020 (USD million)
14. Asia Pacific point of care decentralized clinical chemistry diagnostics revenue, 2012 - 2020 (USD million)
15. Asia Pacific point of care infectious disease testing revenue, 2012 - 2020 (USD million)
16. Asia Pacific point of care coagulation diagnostics revenue, 2012 - 2020 (USD million)
17. Asia Pacific point of care primary care systems revenue, 2012 - 2020 (USD million)
18. Asia Pacific point of care hematology diagnostics revenue, 2012 - 2020 (USD million)
19. Asia Pacific point of care urinalysis diagnostics revenue, 2012 - 2020 (USD million)
20. Asia Pacific point of care drug abuse testing revenue, 2012 - 2020 (USD million)
21. Asia Pacific point of care feces testing revenue, 2012 - 2020 (USD million)
22. Japan PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
23. Japan PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
24. Australia PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
25. Australia PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
26. China PoC diagnostics revenue, by products, 2012 - 2020 (USD million) 59
27. China PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
28. India PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
29. India PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
30. Thailand PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
31. Thailand PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
32. South Korea PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
33. South Korea PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
34. New Zealand PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
35. New Zealand PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
36. Singapore PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
37. Singapore PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
38. Hong Kong PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
39. Hong Kong PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
40. Philippines PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
41. Philippines PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
42. Taiwan PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
43. Taiwan PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
44. Malaysia PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
45. Malaysia PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
46. Vietnam PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
47. Vietnam PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
48. Pakistan PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
49. Pakistan PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
50. Indonesia PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
51. Indonesia PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)
52. Rest of Asia Pacific PoC diagnostics revenue, by products, 2012 - 2020 (USD million)
53. Rest of Asia Pacific PoC diagnostics revenue, by end-users, 2012 - 2020 (USD million)


List of Figures

1. Asia Pacific PoC Diagnostics: Market Segmentation
2. Asia Pacific PoC Diagnostics Market Revenue, 2012 - 2020 (USD million)
3. Asia Pacific PoC Diagnostics Market Dynamics
4. Global percentage of population, by age group, 2000 and 2050
5. Regional breakdown of population over the age of 65 years, by region, 2010 and 2050
6. Asia Pacific PoC diagnostics revenue share by product, 2012 & 2020
7. Asia Pacific PoC diagnostics revenue share by country, 2012 & 2020
8. Japan PoC diagnostics revenue, 2012 - 2020 (USD million)
9. Australia PoC diagnostics revenue, 2012 - 2020 (USD million)
10. Australia blood gas and electrolytes company market share analysis, 2013
11. Australia decentralized clinical chemistry company market share analysis, 2013
12. Australia infectious disease testing company market share analysis, 2013
13. Australia hematology company market share analysis, 2013
14. Australia: coagulation company market share analysis, 2013
15. Australia OTC and rapid diagnostics company market share analysis, 2013
16. Australia cardiac markers company market share analysis, 2013
17. Australia primary care systems company market share analysis, 2013
18. Australia urinalysis company market share analysis, 2013
19. Australia drug abuse testing company market share analysis, 2013
20. Australia feces testing company market share analysis, 2013
21. Australia fertility testing company market share analysis, 2013
22. Australia glucose testing company market share analysis, 2013
23. China PoC diagnostics revenue, 2012 - 2020 (USD million)
24. China blood gas and electrolytes company market share analysis, 2013
25. China decentralized clinical chemistry company market share analysis, 2013
26. China infectious disease testing company market share analysis, 2013
27. China hematology company market share analysis, 2013
28. China coagulation company market share analysis, 2013
29. China OTC and rapid diagnostics company market share analysis, 2013
30. China cardiac markers company market share analysis, 2013
31. China primary care systems company market share analysis, 2013
32. China urinalysis company market share analysis, 2013
33. China drug abuse testing company market share analysis, 2013
34. China feces testing company market share analysis, 2013
35. China fertility testing company market share analysis, 2013
36. China glucose testing company market share analysis, 2013
37. India PoC diagnostics revenue, 2012 - 2020 (USD million)
38. India blood gas and electrolytes company market share analysis, 2013
39. India decentralized clinical chemistry company market share analysis, 2013
40. India infectious disease testing company market share analysis, 2013
41. India hematology company market share analysis, 2013
42. India coagulation company market share analysis, 2013
43. India OTC and rapid diagnostics company market share analysis, 2013
44. India cardiac markers company market share analysis, 2013
45. India primary care systems company market share analysis, 2013
46. India urinalysis company market share analysis, 2013
47. India drug abuse testing company market share analysis, 2013
48. India feces testing company market share analysis, 2013 75
49. India fertility testing company market share analysis, 2013
50. India glucose testing company market share analysis, 2013
51. Thailand PoC diagnostics revenue, 2012 - 2020 (USD million)
52. Thailand blood gas and electrolytes company market share analysis, 2013
53. Thailand decentralized clinical chemistry company market share analysis, 2013
54. Thailand infectious disease testing company market share analysis, 2013
55. Thailand hematology company market share analysis, 2013
56. Thailand coagulation company market share analysis, 2013
57. Thailand OTC and rapid diagnostics company market share analysis, 2013
58. Thailand cardiac markers company market share analysis, 2013
59. Thailand primary care systems company market share analysis, 2013
60. Thailand urinalysis company market share analysis, 2013
61. Thailand drug abuse testing company market share analysis, 2013
62. Thailand feces testing company market share analysis, 2013
63. Thailand fertility testing company market share analysis, 2013
64. Thailand glucose testing company market share analysis, 2013
65. South Korea PoC diagnostics revenue, 2012 - 2020 (USD million)
66. South Korea blood gas and electrolytes company market share analysis, 2013
67. South Korea decentralized clinical chemistry company market share analysis, 2013
68. South Korea infectious disease testing company market share analysis, 2013
69. South Korea hematology company market share analysis, 2013
70. South Korea coagulation company market share analysis, 2013
71. South Korea OTC and rapid diagnostics company market share analysis, 2013
72. South Korea cardiac markers company market share analysis, 2013
73. South Korea primary care systems company market share analysis, 2013
74. South Korea urinalysis company market share analysis, 2013
75. South Korea drug abuse testing company market share analysis, 2013
76. South Korea feces testing company market share analysis, 2013
77. South Korea fertility testing company market share analysis, 2013
78. South Korea glucose testing company market share analysis, 2013
79. New Zealand PoC diagnostics revenue, 2012 - 2020 (USD million)
80. Singapore PoC diagnostics revenue, 2012 - 2020 (USD million) 100
81. Hong Kong PoC diagnostics revenue, 2012 - 2020 (USD million) 103
82. Philippines PoC diagnostics revenue, 2012 - 2020 (USD million)
83. Taiwan PoC diagnostics revenue, 2012 - 2020 (USD million)
84. Malaysia PoC diagnostics revenue, 2012 - 2020 (USD million)
85. Vietnam PoC diagnostics revenue, 2012 - 2020 (USD million)
86. Pakistan PoC diagnostics revenue, 2012 - 2020 (USD million)
87. Indonesia PoC diagnostics revenue, 2012 - 2020 (USD million)
88. RoAPAC PoC diagnostics revenue, 2012 - 2020 (USD million)
89. Asia Pacific PoC diagnostics revenue share by end-user, 2012 & 2020
90. Asia Pacific PoC diagnostics based hospitals revenue, 2012 - 2020 (USD million)
91. Asia Pacific PoC diagnostics based clinics revenue, 2012 - 2020 (USD million)
92. Asia Pacific PoC diagnostics based laboratories revenue, 2012 - 2020 (USD million)
93. Asia Pacific PoC diagnostics based assisted living healthcare facilities revenue, 2012 - 2020 (USD million)
94. Asia Pacific PoC diagnostics based home healthcare revenue, 2012 - 2020 (USD million)
95. Asia Pacific PoC diagnostics based other facilities revenue, 2012 - 2020 (USD million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.